The "Asia Pacific Antibiotics Market By Action Mechanism, By Drug Class, By Country, Industry Analysis and Forecast, 2020 – 2026" report has been added to ResearchAndMarkets.com’s offering. The Asia ...
Hosted on MSN
Chlorotonils: Naturals antibiotics' dual-action mechanism against multidrug-resistant pathogens uncovered
The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome these resistances, drugs with novel modes of action are urgently needed.
STATEN ISLAND, N.Y., Oct. 28, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of ...
The intravenous formulation of fosfomycin has a novel mechanism of action an no known cross-resistance to other antibiotic classes.
The rise of antimicrobial-resistant pathogens has spurred scientists to search far and wide for new drugs. And while many antimicrobial molecules have been discovered in recent years, it’s rare to ...
About a decade ago, researchers in UC Santa Barbara chemistry professor Guillermo Bazan’s lab began to observe a recurring challenge in their research: Some of the compounds they were developing to ...
As more and more pathogenic bacteria gain resistance to commonly used antibiotics, the search for new, effective, and safe antibiotics has become vital. According to The Lancet, almost 5 million ...
1don MSN
Time to act and not react: How can the European Union turn the tide of antimicrobial resistance?
Despite determined efforts by countries and health care professionals, Europe is not on track to meet four of the five AMR ...
The U.S. FDA has approved intravenous fosfomycin (Contepo) for treating adults with complicated urinary tract infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback